Good Clinical Practice & Pharmacovigilance Compliance Symposium Day One - PM

แชร์
ฝัง
  • เผยแพร่เมื่อ 6 ม.ค. 2025
  • This Joint US-FDA, MHRA-UK, Health Canada workshop focused on Global Clinical Trials in Good Clinical Practice, Bioequivalence, and Pharmacovigilance in the post pandemic world. Panelists discussed continuing developments in novel operational approaches, data sources, and technologies used in clinicals trials, as well as novel approaches to regulatory inspections.
    Timestamps
    00:01 - Session 4 - ICH E6 (R3) Draft - Good Data Governance Practices
    54:24 - Session 1 Discussion Panel
    01:06:32 - Session 2 Discussion Panel
    01:20:14 - Session 3 Discussion Panel
    01:33:48 - Session 4 Discussion Panel
    01:42:45 - Day One Wrap-Up & Closing Remarks
    Speakers | Panelists:
    Cheryl Grandinetti, PharmD
    Clinical Pharmacologist
    Division of Clinical Compliance Evaluation (DCCE)
    Office of Scientific Investigations (OSI)
    Office of Compliance (OC)
    Center for Drug Evaluation and Research (CDER) | FDA
    Shila Rastegar, MSc
    Regulatory Compliance and Enforcement Specialist
    Clinical Trial Compliance Program (CTCP)
    Regulatory Operations and Enforcement Branch (ROEB)
    Health Canada (HC)
    Andrew Fisher, BSc
    Lead Senior Good Clinical Practice (GCP) Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA)
    Regina Zopf, MD
    Senior Medical Officer
    Good Clinical Practice Assessment Branch (GCPAB)
    DCCE | OSI | OC | CDER | FDA
    Leigh Marcus, MD
    Senior Physician
    DCCE | OSI | OC | CDER | FDA
    Hocine Abid, MD, MBA
    National Manager
    Regulatory Operations and Enforcement Branch (ROEB)
    Health Canada (HC)
    Debbi Fox, BSc
    Compliance Specialist
    ROEB | HC
    Elena Boley, MD, MBA
    Senior Physician
    DCCE | OSI | OC | CDER | FDA
    Mandy Budwal-Jagait, MSc
    Head of GCP and Lead Senior GCP Inspector
    MHRA
    Jason Wakelin-Smith, BSc
    Expert GCP Inspector and Head of the Compliance Expert Circle
    MHRA
    Lee Pai-Scherf, MD
    Senior Medical Officer
    Good Clinical Practice Assessment Branch (GCPAB)
    DCCE | OSI | OC | CDER | FDA
    Learn more at: www.fda.gov/dr...
    -----------------------
    FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
    Upcoming Training - www.fda.gov/cd...
    SBIA Listserv - public.govdeli...
    SBIA 2022 Playlist - • 2022 CDER Small Busine...
    SBIA LinkedIn -  / cder-small-business-an...
    SBIA Training Resources - www.fda.gov/cd...
    Twitter -  / fda_drug_info
    Email - CDERSBIA@fda.hhs.gov
    Phone - (301) 796-6707 I (866) 405-5367

ความคิดเห็น •